Low-Grade Pseudomyxoma Peritonei Behaving as a High-Grade Disease: A Case Series and Literature Review
Patients with low-grade appendiceal mucinous carcinomas (LAMNs) treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have a favorable prognosis. However, a subgroup of patients presents a clinically aggressive course with disease progression despite receivin...
Main Authors: | Petros Bangeas, Dimitrios Kyziridis, Apostolos Kalakonas, Apostolis A. Tentes |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/30/11/726 |
Similar Items
-
Novel Perspectives in Pseudomyxoma Peritonei Treatment
by: Antonio Sommariva, et al.
Published: (2021-11-01) -
Diagnostic and Therapeutic Algorithm for Appendiceal Tumors and Pseudomyxoma Peritonei: A Consensus of the Peritoneal Malignancies Oncoteam of the Italian Society of Surgical Oncology (SICO)
by: Marco Vaira, et al.
Published: (2023-01-01) -
Global trends in research of pseudomyxoma peritonei: a bibliometric and visualization analysis
by: Shuo Liu, et al.
Published: (2024-02-01) -
Progress in Biological Research and Treatment of Pseudomyxoma Peritonei
by: Xi Li, et al.
Published: (2024-04-01) -
Post-operative critical care management of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC)
by: Cooksley Timothy J, et al.
Published: (2011-12-01)